Old Web
English
Sign In
Acemap
>
authorDetail
>
Aseem Pandey
Aseem Pandey
Sanofi Pasteur
Medicine
Immunogenicity
Quadrivalent Influenza Vaccine
Pediatrics
Influenza vaccine
4
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial.
2021
Vaccine
Lee-Jah Chang
Evan J. Anderson
Robert Jeanfreau
Ying He
Bryony Hicks
Anju Shrestha
Aseem Pandey
Victoria Landolfi
Iris DeBruijn
Show All
Source
Cite
Save
Citations (0)
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults >= 65 years of age: a Phase II, open-label study
2021
medRxiv
Ruvim Izikson
Daniel Brune
Jean-Sébastien Bolduc
Pierre Bourron
Marion Fournier
Tamala Mallett Moore
Aseem Pandey
Lucia Perez
Nessryne Sater
Anju Shrestha
Sophie Wagué
Sandrine I. Samson
Show All
Source
Cite
Save
Citations (0)
160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age
2020
Open Forum Infectious Diseases
Lee-Jah Chang
Evan J. Anderson
Robert Jeanfreau
Ying He
Bryony Hicks
Anju Shrestha
Aseem Pandey
Rawia Khoury
Iris De Bruijn
Victoria Landolfi
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial
2019
Human Vaccines & Immunotherapeutics
Leilani Sanchez
Osamu Matsuoka
Satoshi Inoue
Takahiro Inoue
Ya Meng
Takahiro Nakama
Kumiko Kato
Aseem Pandey
Lee-Jah Chang
Show All
Source
Cite
Save
Citations (9)
1